Skip to main content
CIN- L67120MH1995PLC084899
 

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID



Dr. Lal Pathlabs Ltd.

NSE : LALPATHLABEQ BSE : 539524 ISIN CODE : INE600L01024Industry : Hospitals & Medical Services

News

  • Dr. Lal Pathlabs - General Updates 12 Jun 2026 | 20:32 | Dion Global

    Dr. Lal Path Labs Ltd. has informed the Exchange about General Updates- Update on Incorporation of Wholly Owned Subsidiary Companymore...

  • Dr. Lal Pathlabs - Update On Incorporation Of A Wholly Owned Subsidiary Company 12 Jun 2026 | 20:24 | Dion Global

    Attachedmore...

  • Dr. Lal Pathlabs - Analysts/Institutional Investor Meet/Con. Call Updates 13 May 2026 | 18:01 | Dion Global

    Dr. Lal Path Labs Ltd. has informed the Exchange about Schedule of meetmore...

  • Dr. Lal Pathlabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 13 May 2026 | 17:41 | Dion Global

    Attachedmore...

  • Dr. Lal Pathlabs has declared 40% Final dividend for the financial year March 2026 13 May 2026 | 16:18 | Dion Global

    Dr. Lal Pathlabs Ltd. on Thursday 30 April 2026 has announced Final dividend of 40 percent on Equity Share to its shareholders holding shares on the ...more...

  • Dr. Lal Pathlabs - Announcement under Regulation 30 (LODR)-Earnings Call Transcript 06 May 2026 | 18:12 | Dion Global

    Attachedmore...

  • Dr. Lal Pathlabs - Analysts/Institutional Investor Meet/Con. Call Updates 06 May 2026 | 18:09 | Dion Global

    Dr. Lal Path Labs Ltd. has informed the Exchange about Transcriptmore...

  • Dr. Lal Pathlabs - Disclosure under SEBI Takeover Regulations 04 May 2026 | 22:55 | Dion Global

    ÿDr. Vandana Lalÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Su...more...

  • Dr. Lal Pathlabs - Disclosure under SEBI Takeover Regulations 04 May 2026 | 22:54 | Dion Global

    ÿDr. Vandana Lalÿÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantia...more...

  • Dr. Lal Pathlabs - General Updates 01 May 2026 | 19:18 | Dion Global

    Dr. Lal Path Labs Ltd. has informed the Exchange about General Updates - Update on Acquisitionmore...

  • Dr. Lal Pathlabs - Announcement under Regulation 30 (LODR)-Updates on Acquisition 01 May 2026 | 19:18 | Dion Global

    Attachedmore...

  • Dr. Lal Pathlabs - Copy of Newspaper Publication 01 May 2026 | 15:03 | Dion Global

    Dr. Lal Path Labs Ltd. has informed the Exchange about Copy of Newspaper Publicationmore...

  • Dr. Lal Pathlabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 30 Apr 2026 | 19:10 | Dion Global

    Attachedmore...

  • Dr. Lal Pathlabs - Analysts/Institutional Investor Meet/Con. Call Updates 30 Apr 2026 | 19:08 | Dion Global

    Dr. Lal Path Labs Ltd. has informed the Exchange about Link of Recordingmore...

  • Dr. Lal Pathlabs Q4 net profit down 4.92% at Rs 141.10 cr 30 Apr 2026 | 16:10 | Dion Global

    The company reported standalone net profit of Rs 141.10 crore for the quarter ended March 31 2026 as compared to Rs 148.40 crore in the same period l...more...

  • Dr. Lal Pathlabs - Announcement under Regulation 30 (LODR)-Investor Presentation 30 Apr 2026 | 16:10 | Dion Global

    Attachedmore...

  • Dr. Lal Pathlabs - Investor Presentation 30 Apr 2026 | 16:09 | Dion Global

    Dr. Lal Path Labs Ltd. has informed the Exchange about Investor Presentationmore...

  • Dr. Lal Pathlabs - Press Release 30 Apr 2026 | 16:07 | Dion Global

    Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated April 30 2026 titled Press Release on Audited Financial Res...more...

  • Dr. Lal Pathlabs - Announcement under Regulation 30 (LODR)-Press Release / Media Release 30 Apr 2026 | 16:07 | Dion Global

    Attachedmore...

  • Dr. Lal Pathlabs - General Updates 30 Apr 2026 | 15:45 | Dion Global

    Dr. Lal Path Labs Ltd. has informed the Exchange about re-appointment of Auditor(s):1. M/s Ernst & Young LLP (EY) as the Internal Auditors o...more...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex77231.230.56%
NSE Index24124.750.46%
B500DIVL503535.640.71%
BSE 1000 10877.160.54%
BSE 100LCTMC9093.840.48%
BSE Auto 59007.220.57%

Commodity

Gold144606-2.08%
Silver231829-3.94%
Copper1330.25226.20%
Crude Oil722212.62%
Lead206.553.65%
Mentha Oil1091.92.30%
Nickel1708.3122.75%

Currency

USD/INR 94.70(0.02 %)
GBP/INR 126.91(-0.31 %)
EUR/INR 109.70(-0.19 %)
JPY/INR 0.59(-0.21 %)
CAD/INR 67.68(0.02 %)
HKD/INR 12.09(0.03 %)